Effects of 3, 5, 2', 4'-tetrahydroxychalcone on serum uric acid levels and the content of hepatic XOD/XDH in mice
- Author:
Yan-Fen NIU
1
Author Information
- Publication Type:Journal Article
- Keywords: 3, 5, 2', 4'-tetrahydroxychalcone (compound P40); Hyperuricemia; Time-and dose-dependent relationship; Uric acid (UA); Xanthine dehydrogenase (XDH); Xanthine oxidase (XOD)
- From: Chinese Pharmaceutical Journal 2015;50(1):34-38
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To investigate the time- and dose-dependent effects of 3, 5, 2', 4'-tetrahydroxy chalcone (P40) on the levels of uric acid and the contents of hepatic xanthine dehydrogenase (XDH) and xanthine oxidase (XOD) in the hyperuricemic mice induced by potassium oxonate. METHODS: The hyperuricemic mice were induced by an intraperitoneal injection of uricase inhibitor potassium oxonate. Serum uric acid levels were determined by using tie phosphotungstic acid method. The contents of hepatic XOD and XDH were determined using commercially available Elisa kits. Allopurinol was as a positive control. RESULTS: When orally administrated to the oxonate-induced hyperuricemic mice, compound P40 at doses of 0.5, 1.0, 2.0, 4.0 mg · kg-1 and the allopurinol at a doses of 1.0 mg · kg-1 significantly decreased the uric acid levels and reduced the concentration of XOD compared with model group. As for the study of time-dependent effects: after administration of allopurinol 30 min or P40 60 min effectively reduced serum uric acid levels compared to the model group, respectively. Administration with P40 and allopurinol for 15, 30, 60, 90 min can reduce the concentration of XDH and XOD, compared with model group. CONCLUSION: P40 could reduce the serum uric acid levels in oxonate-induced hyperuricemic mice by reducing the contents of hepatic XDH/XOD.
